Results 81 to 90 of about 34,860 (269)
Biodegradable collagen matrix implant vs mitomycin-C as an adjuvant in trabeculectomy: a 24-month, randomized clinical trial [PDF]
AIM: To verify the safety and efficacy of Ologen (OLO) implant as adjuvant compared with low-dosage mitomycin-C (MMC) in trabeculectomy. METHODS: This was a prospective randomized clinical trial with a 24-month follow-up.
A Casuccio +39 more
core +1 more source
Abstract Purpose To compare the inflammatory response in the eye after trabeculectomy to after phacoemulsification, focusing on anterior chamber flare (AC flare) and central macular thickness (CMT). Methods Data from 436 participants in two randomized controlled trials were analysed.
Yasmeen Ahmed +5 more
wiley +1 more source
AIM:To evaluate the outcomes of trabeculectomy with large area mitomycin-C (MMC) application as a first line treatment in advanced glaucoma.METHODS:The records of 55 patients with severe visual field defects undergoing trabeculectomy were retrospectively
Zeynep Aktas +4 more
doaj +1 more source
Long-Term Efficacy and Safety of Modified Canaloplasty Versus Trabeculectomy in Open-Angle Glaucoma
Background: To evaluate the long-term efficacy and safety of modified canaloplasty versus trabeculectomy in open-angle glaucoma. Methods: In total, 210 subjects with open-angle glaucoma were included.
Julia V. Stingl +8 more
doaj +1 more source
Intracameral bevacizumab administration in trabeculectomy surgery. [PDF]
Theodoros Filippopoulos
openalex +1 more source
Association Between Prior Selective Laser Trabeculoplasty and Phaco‐iStent Inject Efficacy
ABSTRACT Background To evaluate the association between prior selective laser trabeculoplasty (SLT) on intraocular pressure (IOP) lowering efficacy of phacoemulsification combined with iStent inject (phaco‐iStent). Methods Retrospective study of 1550 eyes of 1023 patients with and without prior SLT that underwent phaco‐iStent.
Jeremy C. K. Tan +8 more
wiley +1 more source
ABSTRACT Background The bleb‐forming surgical spectrum in open‐angle glaucoma has recently been expanded by novel surgical approaches. Through a medical device implantation (Xen Gel Stent (XGI) or Preserflo Microshunt (PMI)), these procedures aim at more standardised aqueous humour shunting and an intra‐ and postoperative risk reduction ...
Martin Kallab +3 more
wiley +1 more source
Baerveldt tube implantation following failed deep sclerectomy versus repeat deep sclerectomy. [PDF]
PURPOSE: To compare the surgical outcomes of repeat deep sclerectomy (DS) and the Baerveldt glaucoma implant (BGI) in eyes with failed primary deep sclerectomy. DESIGN: A retrospective comparative case-control study.
Bergin, C. +4 more
core +1 more source
Naoki Tojo, Mitsuya Otsuka, Atsushi Hayashi Department of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan Purpose: To compare the postoperative interventions and outcomes between conventional ...
Tojo N, Otsuka M, Hayashi A
doaj
Minimally Invasive Glaucoma Surgery: Is It Here to Stay?
ABSTRACT The advent of minimally invasive glaucoma surgery (MIGS) has expanded the treatment options available for glaucoma by providing options for reducing intraocular pressure without the serious complication profile associated with incisional glaucoma surgery.
Neeranjali Jain, Jennifer C. Fan Gaskin
wiley +1 more source

